RPP30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.201640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.104500E-02
Normal-vs-Stage2
1.299840E-01
Normal-vs-Stage3
2.660200E-01
Normal-vs-Stage4
1.878610E-01
Stage1-vs-Stage2
5.984400E-01
Stage1-vs-Stage3
9.505400E-01
Stage1-vs-Stage4
8.669000E-01
Stage2-vs-Stage3
6.075800E-01
Stage2-vs-Stage4
8.098000E-01
Stage3-vs-Stage4
8.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.263440E-01
Normal-vs-AfricanAmerican
6.554300E-02
Normal-vs-Asian
8.629900E-02
Caucasian-vs-AfricanAmerican
4.304000E-01
Caucasian-vs-Asian
9.171600E-01
AfricanAmerican-vs-Asian
3.566400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.538010E-01
Normal-vs-Female
9.779600E-02
Male-vs-Female
6.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.194400E-01
Normal-vs-Age(41-60Yrs)
1.539390E-01
Normal-vs-Age(61-80Yrs)
1.175150E-01
Normal-vs-Age(81-100Yrs)
5.864100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.978600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.663400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.902600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.571700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.312800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.540180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.184300E-02
Normal-vs-Daily Drinker
7.733900E-02
Normal-vs-Weekly Drinker
1.598180E-01
Normal-vs-Occasional Drinker
3.926200E-01
Normal-vs-Social Drinker
9.725700E-02
Non Drinker-vs-Daily Drinker
9.906600E-01
Non Drinker-vs-Weekly Drinker
3.248400E-01
Non Drinker-vs-Occasional Drinker
7.552400E-02
Non Drinker-vs-Social Drinker
7.729000E-01
Daily Drinker-vs-Weekly Drinker
3.275200E-01
Daily Drinker-vs-Occasional Drinker
8.617900E-02
Daily Drinker-vs-Social Drinker
7.702800E-01
Weekly Drinker-vs-Occasional Drinker
4.782600E-01
Weekly Drinker-vs-Social Drinker
5.051000E-01
Occasional Drinker-vs-Social Drinker
1.827610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.650800E-01
Normal-vs-Grade 2
8.084000E-01
Normal-vs-Grade 3
7.776200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.380600E-03
Grade 1-vs-Grade 3
3.340400E-03
Grade 1-vs-Grade 4
9.650800E-01
Grade 2-vs-Grade 3
4.158600E-01
Grade 2-vs-Grade 4
8.084000E-01
Grade 3-vs-Grade 4
7.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.388180E-01
Normal-vs-NonDiabetic
8.720500E-02
Diabetic-vs-NonDiabetic
8.494800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.692390E-01
Normal-vs-NoPancreatitis
1.039200E-01
Pancreatitis-vs-NoPancreatitis
3.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.430640E-01
Normal-vs-N1
1.234610E-01
N0-vs-N1
6.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.924600E-01
Normal-vs-TP53-NonMutant
1.211650E-01
TP53-Mutant-vs-TP53-NonMutant
2.835600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
